2007•Zhongguo yaofangRequires access

Cost-Effectiveness Analysis of Three Therapies for Children’s Bronchopneumonia

Lifang Zhou

Abstract

OBJECTIVE:To select the best therapeutic regimen for children’s bronchopneumonia.METHODS:A retrospective study was conducted on the cost-effectiveness of cephathiamidin(group A),cefuroxime sodium(group B) and ceftriaxone sodium(group C) in treatment of children’s bronchopneumonia.RESULTS:The total effective rates of group A,B and C were respectively 97.3%,94.1% and 91.1%(P0.05),against respective costs of 3 046.59 yuan,3 202.42 yuan and 3 749.75 yuan.The three groups’ cost-effectiveness ratios were 3 131.13,3 403.21 and 4 116.08.As compared with group A,the incre-mental cost-effectiveness ratios of groups B and C were —4 869.69 and —11 341.29 respectively.CONCLUSIONS:Cephathiamidin is more cost-effective in treatment of children’s bronchopneumonia.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Bronchopneumonia, Medicine, Regimen, Internal medicine, Group B, Pediatrics